ロード中...
Current state and outlook for drug repositioning anticipated in the field of ovarian cancer
Ovarian cancer is the seventh most common cancer and the eighth most common cause of cancer mortality in women. Although standard chemotherapy is the established treatment for ovarian cancer, the prognosis remains poor, and it is highly anticipated that new drugs will be developed. New drugs, such a...
保存先:
| 出版年: | J Gynecol Oncol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6304407/ https://ncbi.nlm.nih.gov/pubmed/30479094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2019.30.e10 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|